#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endocrine ophthalmopathy Small intestine leiomyosarcoma Prophylaxis against transplant rejection Infantile spasms Ornithine transcarbamoylase deficiency Hypertriglyceridaemia Myxofibrosarcoma Chemical burn Haemophilia A with anti factor VIII Immunodeficiency common variable Mucopolysaccharidosis III Alexander disease Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Hyperphagia Henoch-Schonlein purpura nephritis More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Kearns-Sayre syndrome – Diagnostics Mitochondrial myopathy – Treatment Piriformis syndrome Shprintzen-Goldberg syndrome – Life with Disease Mantle cell lymphoma stage III – Diagnostics Progressive supranuclear palsy – Basic Information Pelizaeus-Merzbacher disease – Diagnostics Hereditary neuropathic amyloidosis – Diagnostics Atypical haemolytic uraemic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alxn2220 Alendronate Sodium Monohydrate Zenocutuzumab Carbasalate Calcium Lovo-B Methadone Hydrochloride Mepolizumab XYLOMETAZOLINE HYDROCHLORIDE GSKVX000000048111 Ads-013 Bay 3283142 Evx-01 Cortisone Acetate Finasteride Copanlisib Dihydrochloride Etelcalcetide Satoreotide Tetraxetan FRUQUINTINIB Azd5462 Clomipramine Hydrochloride More therapies…

    Learn about Your Condition

    Post cardiac arrest syndrome Progressive supranuclear palsy HER2 negative breast cancer Angiopathy Malignant glioma Basal cell naevus syndrome Diabetic gastroparesis Coronary artery occlusion Immunosuppression Retinal vein occlusion Acute promyelocytic leukaemia Desmoid tumour Gaucher's disease type III B-cell lymphoma Andersen-Tawil syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Use of Sulfur Hexafluoride in Ultrasound for Diagnosing Adnexal Torsion in Patients with Suspected Ovarian Twisting

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sulfur Hexafluoride
    France

  • Study Comparing Subcutaneous and Intravenous Paracetamol for Pain Relief in Adult Palliative Care Patients

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Paracetamol
    France

  • Study on Chemo-Immunotherapy with Avelumab for Patients with Locally Advanced Urothelial Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Avelumab
    The Netherlands

  • Study Comparing ARI-0001 and Axicabtagene Ciloleucel for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Varnimcabtagene Autoleucel
    • Axicabtagene Ciloleucel
    The Netherlands

  • Study on the Effectiveness of Oxaliplatin, Docetaxel, and Fluorouracil in Patients with Resectable Gastric and Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Cisplatin
    • Docetaxel
    Germany

  • Study on the Effects of Atorvastatin for Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    Investigated Drugs:
    • Atorvastatin
    Denmark
Previous Page
1 … 632 633 634 635 636 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!